Not applicableStudy completedNCT01720706What this trial is testingThermal Ablation in Larger Liver and Kidney TumoursWho this might be right forLiver and Kidney Tumours University Health Network, Toronto 12
Testing effectiveness (Phase 2)Study completedNCT00101114What this trial is testingSorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more National Cancer Institute (NCI) 55
Not applicableStudy completedNCT02732652What this trial is testingGlycosaminoglycan Scores as Monitoring Biomarkers in Confined Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Chalmers University of Technology 72
Testing effectiveness (Phase 2)Looking for participantsNCT07594106What this trial is testingREGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell CarcinomaWho this might be right forMetastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC) Regeneron Pharmaceuticals 265
Not applicableStudy completedNCT01887574What this trial is testingRenal Mass RegistryWho this might be right forRenal Cell Carcinoma Mayo Clinic 141
Testing effectiveness (Phase 2)Ended earlyNCT05119335What this trial is testingNKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell CarcinomaWho this might be right forccRCCClear Cell Renal Cell CarcinomaKidney Cancer+14 more NiKang Therapeutics, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT00265135What this trial is testingCNTO 328 in Subjects With Metastatic Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Centocor, Inc. 68
Testing effectiveness (Phase 2)Study completedNCT00619268What this trial is testingCombination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Centre Leon Berard 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725What this trial is testingLow Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289What this trial is testingCeralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid TumorsWho this might be right forClear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more Rahul Aggarwal 83
Early research (Phase 1)Active Not RecruitingNCT02496208What this trial is testingCabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsWho this might be right forBladder Small Cell Neuroendocrine CarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+27 more National Cancer Institute (NCI) 152
Testing effectiveness (Phase 2)Ended earlyNCT00523640What this trial is testingA Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell University of Chicago 30
Not applicableLooking for participantsNCT07171190What this trial is testingTargeted Abdominal CT in Conjunction With Lung Cancer ScreeningWho this might be right forRenal Cell Carcinoma (Kidney Cancer)Kidney CancersAAA - Abdominal Aortic Aneurysm+1 more University of Cambridge 6,272
Large-scale testing (Phase 3)Ended earlyNCT03013946What this trial is testingRole of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line TherapyWho this might be right forRenal Cell Carcinoma, MetastaticRenal Cell Cancer, Recurrent AIO-Studien-gGmbH 121
Testing effectiveness (Phase 2)Study completedNCT00425386What this trial is testingSunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney CancerWho this might be right forKidney Cancer OHSU Knight Cancer Institute 60
Large-scale testing (Phase 3)Enrolling By InvitationNCT07620574What this trial is testingLong-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored StudyWho this might be right forCancerRenal Cell Carcinoma (RCC)Pancreatic Neuroendocrine Tumors (pNET)+6 more Exelixis 5,000
Testing effectiveness (Phase 2)UnknownNCT00610389What this trial is testingPhase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid TumorsWho this might be right forRenal Cell CarcinomaMelanomaCarcinoma, Hepatocellular Clinica Universidad de Navarra, Universidad de Navarra 27
Not applicableNot Yet RecruitingNCT07233668What this trial is testingImmediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCCWho this might be right forMetastatic Renal Cell Carcinoma ( mRCC) Seoul National University Hospital 172
Testing effectiveness (Phase 2)Ended earlyNCT01253668What this trial is testingBrivanib Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)Study completedNCT01664182What this trial is testingTrebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney CancerWho this might be right forAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+1 more National Cancer Institute (NCI) 41